rotavirus
rv
remain
one
two
import
viral
caus
gastroenter
despit
avail
sever
safe
effect
live
attenu
vaccin
rotaviru
infect
biggest
health
impact
children
age
year
still
account
approxim
death
annual
almost
entir
lessdevelop
countri
rv
infect
mani
cell
nonimmun
host
overwhelm
bulk
viral
replic
occur
matur
villu
tip
cell
small
intestin
review
focu
regul
rotaviru
replic
host
innat
immun
system
hostrestrict
natur
innat
immun
respons
specif
rotaviru
strain
practic
util
host
rang
barrier
develop
safe
effect
rv
vaccin
infect
rv
result
immedi
activ
conserv
cellular
innat
immun
signal
pathway
involv
multipl
pattern
recognit
receptor
prr
recogn
discret
rvencod
pathogenassoci
molecular
pattern
pamp
primari
purpos
divers
hostsign
system
induc
differ
type
interferon
ifn
set
virusinduc
stress
gene
visg
two
princip
transcript
factor
nuclear
ifn
regulatori
factor
induc
ifn
visg
function
restrict
rv
replic
pathogeninduc
cell
injuri
note
rv
like
virtual
viral
pathogen
evolv
set
countermeasur
inhibit
host
innat
immun
respons
countermeasur
pronounc
homolog
rv
infect
rv
infect
strain
routin
isol
specif
host
speci
interestingli
rv
strain
differ
abil
regul
secret
ifn
similarli
induc
earli
recognit
pathway
indic
transcript
upregul
ifn
sever
visg
base
collect
evid
initi
rv
transcript
engag
two
relat
prr
rigi
member
famili
rigilik
receptor
rlr
trigger
activ
mitochondri
antiviralsign
protein
mav
receptor
like
stimul
earli
rv
transcript
byproduct
expos
phosphat
group
incomplet
methyl
cap
structur
local
dsrna
structur
panhandl
loop
viral
transcript
addit
induc
secret
differ
ifn
rlr
respons
rv
like
orchestr
host
respons
rotaviru
activ
result
apoptosi
occur
mostli
pancrea
rvinfect
mice
indic
prrdepend
consequ
occur
cell
organ
typespecif
fashion
chapter
innat
immun
mucos
surfac
addit
rigiand
host
respons
rv
rna
sensor
also
recruit
innat
immun
machineri
trigger
earli
antirv
respons
among
third
member
rlr
famili
seem
exert
provir
effect
rv
replic
whose
activ
rv
infect
may
repres
viral
strategi
dampen
pathway
yet
anoth
player
innat
recognit
rv
dsrnadepend
protein
kinas
pkr
essenti
rvinfect
cell
secret
ifn
molecular
basi
pkr
role
rv
infect
well
understood
given
import
pkr
antivir
signal
gener
inhibit
major
virus
pkr
like
import
rv
pathogen
distinct
cytosol
receptor
discuss
rv
recognit
also
involv
tolllik
receptor
tlr
class
viral
receptor
function
context
cellular
membran
includ
surfac
endosom
membran
compon
aspect
innat
rv
recognit
possibl
reflect
rv
entri
process
exploit
endosom
vesicl
transport
gain
access
host
cell
far
implic
potenti
player
innat
rv
detect
cascad
abil
recogn
regul
rv
thu
perpetu
antivir
effect
tie
agedepend
express
intestin
sinc
rv
typic
caus
sever
diseas
replic
intestin
infant
young
children
mani
mammalian
speci
coincident
lower
level
express
infant
one
possibl
implic
agerestrict
rv
intestin
replic
partli
due
enhanc
signal
age
mucos
compart
tlr
play
special
role
discret
type
cell
rv
infect
rvencod
enterotoxin
may
function
pamp
macrophag
trigger
inflammatori
cytokin
secret
pathway
rv
infect
human
enteroid
cultur
differ
speci
mammal
differ
type
ifn
secret
discuss
antivir
action
ifn
activ
counter
hostrangespecif
manner
pathogen
rv
ifn
type
ifn
mostli
express
intestin
hematopoiet
cell
compart
rather
epithelium
rv
primarili
replic
studi
date
implic
tlrdepend
signal
dendrit
cell
type
ifn
secret
process
rv
infect
infect
plasmacytoid
dendrit
cell
rv
major
sourc
type
ifn
secret
viral
infect
lead
endosomedepend
possibl
type
ifn
secret
trigger
viral
genom
dsrna
potenti
rv
structur
protein
central
role
tlrdepend
defens
rv
also
indic
find
absenc
essenti
converg
adaptor
signal
differ
tlr
result
increas
rv
infect
sever
diarrhea
impair
humor
immun
addit
rv
suscept
antivir
effect
sinc
activ
receptor
bacteri
flagellin
prevent
cure
rv
infect
process
involv
secret
il
inflammasom
cytosol
multiprotein
complex
remain
quiescent
rest
state
upon
activ
apoptosisassoci
specklik
protein
contain
card
protein
name
asc
encod
pycard
encod
oligomer
mediat
proteolyt
process
proinflammatori
cytokin
poreform
protein
gasdermin
ultim
lead
lytic
form
cell
death
known
pyroptosi
event
contribut
host
defens
bacteri
microbi
infect
also
regul
homeostasi
immun
system
develop
variou
inflammatori
diseas
cancer
although
known
inflammasom
recogn
dna
virus
inflammasom
respond
gener
stress
breach
plasmaendosom
membran
integr
inflammasom
control
rna
viru
replic
less
well
understood
addit
whether
noncanon
inflammasom
oper
cell
type
myeloid
cell
larg
unknown
recent
found
oral
infect
suckl
mice
murin
rvinduc
robust
activ
small
intestin
tissu
indic
potenti
role
inflammasom
rv
pathogenesi
note
contrast
nodlik
receptor
includ
naip
target
delet
intestin
epitheli
cell
iec
suckl
mice
led
increas
diarrhea
rv
shed
fece
intraintestin
viral
replic
compar
wildtyp
pup
highlight
crucial
role
control
rv
replic
mechanist
found
rv
infect
dexhbox
helicas
bind
viral
rna
pamp
interact
activ
downstream
signal
pathway
fig
furthermor
primari
mous
intestin
enteroid
gener
mice
produc
less
underw
less
pyroptosi
compar
wildtyp
enteroid
upon
rv
infect
confirm
role
activ
inflammasom
rv
infect
identif
cascad
novel
rvsens
pathway
open
new
research
direct
inflammasom
sensor
rv
enter
virus
differ
rnabind
protein
rigi
etc
coordin
cytoplasm
physiolog
relev
these
sensor
human
intestin
address
fundament
issu
provid
new
insight
biolog
function
host
innat
immun
recognit
acut
rv
infect
gener
overal
human
enter
health
diseas
addit
answer
basic
question
like
inform
practic
consider
develop
better
therapeut
prevent
strategi
enter
infecti
diseas
concept
host
rang
restrict
hrr
central
mani
aspect
rv
replic
diseas
includ
develop
sever
current
avail
safe
effect
rv
vaccin
rv
distinguish
highli
pathogen
infecti
homolog
host
speci
ie
speci
host
normal
infect
particular
rv
strain
speci
rv
strain
spread
effici
rv
also
subject
sever
speciesspecif
restrict
replic
transmiss
heterolog
host
speci
fundament
properti
rv
great
import
viral
pathogen
also
form
basi
sever
licens
live
attenu
oral
administ
rv
vaccin
attenu
virtu
hrr
tradit
continu
cell
line
cultur
system
rv
strain
effici
block
induct
type
ifn
evolv
target
sever
differ
host
factor
regul
ifn
pathway
multiprong
subvers
ifn
respons
accomplish
primarili
versatil
rv
nonstructur
protein
product
rv
gene
see
ifnsensit
rv
strain
encod
form
exhibit
defect
ifn
inhibit
therefor
elicit
enhanc
ifn
secret
although
strain
still
viabl
infecti
agent
abil
replic
substanti
hamper
addit
ifn
sensit
rv
encod
fulllength
function
protein
also
occur
specif
cell
line
possibl
reflect
inabl
target
host
innat
factor
across
differ
speci
enter
infect
suckl
ie
mice
homolog
murin
rv
compar
heterolog
simian
rv
strain
reveal
substanti
log
host
restrict
simian
rv
replic
intestin
host
restrict
phenotyp
substanti
reduc
log
less
mice
lack
three
ifn
receptor
ifnr
key
transcript
factor
relay
antivir
signal
differ
ifnr
replic
phenotyp
strongli
cosegreg
genet
origin
vi
mucos
vaccin
viral
diseas
murin
simian
rv
encod
gene
segment
suckl
mous
thu
present
highli
tractabl
model
ifnspecif
effect
rv
replic
studi
within
biolog
relev
framework
intestin
rv
replic
natur
host
hostrangerestrict
manner
ectop
parenter
inject
purifi
ifn
type
ii
iii
mani
speci
includ
mice
result
activ
key
downstream
transcript
factor
small
iec
predomin
site
rv
replic
multipl
line
evid
indic
import
role
ifn
type
ii
iii
restrict
rv
replic
gut
cell
cultur
mous
embryon
fibroblast
lack
type
ii
ifnr
replic
sever
nonmurin
rv
strain
substanti
enhanc
four
five
order
magnitud
suckl
mice
lack
type
ii
iii
ifnr
either
singli
combin
signific
enhanc
simian
rv
intestin
replic
occur
demonstr
sensit
heterolog
nonmurin
rv
differ
ifn
type
mous
gut
contrast
replic
homolog
murin
rv
quit
resist
ifn
log
less
replic
gain
collect
evid
thu
highlight
import
role
differ
type
ifn
inhibit
rv
protein
rv
pathogen
attenu
deciph
mechan
underli
interact
key
ration
rv
strain
attenu
design
improv
thirdgener
live
attenu
rv
vaccin
manner
analog
rna
virus
rvinduc
ifn
activ
depend
intact
rna
sens
pathway
postrecognit
viral
rna
cytoplasm
sensor
rigi
andor
epitheli
cell
activ
mav
mitochondriaresid
adaptor
protein
altern
known
promot
stimul
card
adapt
induc
ifn
beta
cardif
virusinduc
signal
adapt
visa
mav
serv
central
hub
ifn
induct
pathway
activ
downstream
kinas
includ
tankbind
kinas
inhibitor
kappa
light
polypeptid
gene
enhanc
b
cell
kinas
epsilon
phosphoryl
respect
molecul
transloc
nucleu
upon
phosphoryl
function
transcript
factor
ultim
lead
express
differ
ifn
activ
ifnstimul
respons
element
isr
addit
character
import
transcript
factor
type
ifn
induct
immun
cell
particular
dendrit
cell
similar
undergo
phosphoryl
subsequ
transloc
nucleu
respons
rv
infect
activ
ifn
express
function
transcript
factor
block
import
pathway
rvencod
protein
effici
degrad
virusstraindepend
manner
process
take
place
first
recognit
use
elli
motif
local
ctermin
end
present
molecul
deriv
simian
murin
nonhuman
rv
strain
interact
subsequ
result
rapid
effici
degrad
proteasom
suppress
ifn
product
rvinfect
cell
fig
besid
irf
famili
member
shown
anoth
key
arm
host
innat
immun
respons
downstream
mav
mani
virusinfect
cell
signal
robustli
activ
viru
infect
well
proinflammatori
cytokin
includ
latter
recent
shown
directli
antivir
rv
rv
infect
cell
secret
depend
activ
suckl
mous
model
chemokin
gmcsf
also
upregul
follow
rv
infect
although
whether
canon
cytokin
activ
mav
tlr
remain
unknown
similar
critic
protein
essenti
degrad
cellular
inhibitor
also
target
proteasom
degrad
case
bind
domain
within
map
ctermin
dsgi
motif
human
porcin
rv
strain
importantli
region
elli
motif
respons
bind
mention
interest
dichotomi
interact
may
stem
distinct
contribut
versu
ifn
induct
differ
human
anim
rv
speci
contrast
previou
specul
viral
ligas
due
presenc
ntermin
ring
finger
domain
recent
discov
interest
codestruct
mechan
local
golgi
apparatu
hijack
host
cullin
box
protein
ligas
complex
induc
proteasom
degrad
chemic
blockad
sirna
knockdown
compon
impair
abil
degrad
lead
signific
increas
level
reduc
rv
replic
fig
interestingli
cullin
complex
appear
requir
degrad
suggest
altern
mechan
action
work
recent
unpublish
data
lab
indic
addit
irf
mav
also
subject
rv
inhibit
mav
level
significantli
reduc
rv
infect
process
mediat
surprisingli
rna
methyland
guanylyltransferas
protein
fig
local
mitochondria
bind
mav
ntermin
domain
induc
effici
proteasom
degrad
mav
hostspeciesand
virusstrainspecif
manner
mav
inhibit
anoth
strike
manifest
rv
abil
subvert
host
innat
immun
signal
first
exampl
mav
degrad
enter
viru
would
interest
test
enter
rna
virus
noroviru
antivir
ifn
respons
rv
infect
follow
biphas
pattern
consist
pathway
rv
rna
pamp
activ
rna
sens
pathway
antagon
rvencod
protein
multipl
step
unpublish
studi
shown
directli
induc
proteasom
degrad
mav
addit
differ
rv
strain
degrad
either
latter
mediat
host
cullin
ligas
complex
togeth
rv
protein
work
concert
dampen
ifn
induct
rvinfect
cell
vi
mucos
vaccin
viral
diseas
initi
ifn
induct
phase
follow
ligandmedi
ifn
receptorrelay
amplif
phase
discuss
rv
adept
inhibit
ifn
induct
rv
protein
function
degrad
essenti
factor
andor
ifn
induct
rv
strainspecif
manner
interestingli
spite
viral
antagon
ifn
induct
infect
rv
lead
transcript
induct
secret
differ
ifn
type
cell
cultur
vivo
least
two
factor
contribut
failur
rv
complet
suppress
induct
ifn
secret
first
synthesi
ifn
antagonist
occur
viral
entri
uncoat
virion
rv
transcript
translat
initi
infect
process
sever
byproduct
viral
transcript
gener
act
potent
trigger
ifn
induct
pathway
second
rv
entri
differ
type
cell
may
alway
result
product
infect
exampl
rv
exposur
primari
human
pdc
result
two
distinct
popul
cell
differ
level
viral
infect
dendrit
cell
product
infect
nevertheless
exhibit
robust
activ
ifn
induct
respons
given
remark
effici
ifn
secret
cell
type
like
sourc
substanti
ifn
secret
nonepitheli
cellular
compart
rv
replic
effici
suckl
mice
infect
rv
lead
signific
induct
differ
type
ifn
type
ifn
induc
primarili
intestin
immun
cell
rather
deriv
iec
viral
infect
maxim
secret
ifn
differ
cell
type
pose
uniqu
challeng
success
viral
propag
spread
uninfect
bystand
iec
ifn
bind
cognat
cell
surfac
receptor
activ
posit
feedback
loop
amplifi
express
ifn
well
differ
ifnstimul
gene
ifn
releas
effici
amplifi
express
antivir
protein
target
varieti
viral
replic
step
uninfect
bystand
cell
three
major
ifn
type
ii
iii
found
induc
intestin
follow
rv
infect
capabl
mediat
phosphoryl
key
converg
transcript
factor
event
critic
unlock
transcript
program
result
antivir
state
fig
ifn
type
biolog
relev
context
modul
rv
infect
spread
sever
line
evid
indic
rv
employ
potent
countermeasur
subvert
antivir
state
mediat
secret
ifn
initi
infect
cell
cultur
addit
purifi
exogen
ifn
rv
adsorpt
significantli
hamper
viral
replic
instead
ifn
treatment
cell
prior
rv
infect
requir
achiev
effici
rv
replic
restrict
rv
suckl
mous
model
infect
homolog
murin
rv
infect
heterolog
simian
rv
strain
result
compar
level
induct
differ
ifn
intestin
howev
note
presenc
ifn
infect
neglig
effect
murin
rv
replic
restrict
titer
potent
effect
heterolog
simian
rv
replic
restrict
titer
observ
suggest
order
replic
success
homolog
rv
evolv
strategi
induc
resist
action
differ
secret
ifn
type
cell
prior
actual
infect
bystand
cell
classic
reassort
genet
studi
ifnmedi
replic
phenotyp
murin
simian
rv
implic
constel
rv
gene
encod
viral
protein
determin
resist
ifn
signal
necessari
major
determin
effici
intestin
rv
replic
ifndepend
fashion
direct
evid
rv
subvers
antivir
state
mediat
exogen
ifn
come
find
rvinfect
cell
human
iec
colon
cancer
cell
deriv
line
abl
effici
block
phosphoryl
respons
exogen
ad
purifi
ifn
ii
use
singlecel
analyt
techniqu
ifnmedi
inhibit
found
occur
within
rvinfect
cell
remark
respons
exogen
ifn
ligand
also
potent
inhibit
rv
uninfect
bystand
cell
express
detect
viral
antigen
fig
although
initi
describ
porcin
rv
strain
bystand
inhibitori
effect
observ
vitro
sever
rv
strain
albeit
lower
effici
sen
greenberg
unpublish
observ
abil
rv
block
ifndepend
signal
also
observ
vivo
suckl
mice
infect
murin
rv
abl
significantli
suppress
iec
phosphoryl
subsequ
transcript
occur
respons
parenter
figur
rv
regul
ifn
amplif
pathway
follow
infect
rv
effici
block
exogen
ifndirect
phosphoryl
shown
virusinfect
cell
rv
also
mediat
lysosom
degrad
receptor
type
ii
iii
ifn
unknown
process
along
viral
protein
also
proteasom
degrad
infect
cell
requir
optim
ifn
amplif
respons
addit
rv
inhibit
nuclear
transloc
unknown
mechan
remark
addit
viral
effect
infect
cell
rv
also
potent
inhibit
phosphoryl
uninfect
bystand
cell
respons
differ
type
ifn
viral
host
factor
underli
bystand
inhibit
ifn
unknown
vi
mucos
vaccin
viral
diseas
administ
purifi
ifn
iii
although
transcript
induc
intestin
murin
rvinfect
mice
transcript
analysi
isol
matur
villou
enterocyt
reveal
within
compart
rv
replic
predominantli
occur
infect
bystand
cell
fail
amplifi
type
ifn
gene
villou
epithelium
rv
bystand
cell
also
express
elev
level
transcript
encod
upregul
respons
stimul
cell
secret
ifn
critic
optim
express
sever
antivir
gene
effector
rvinfect
cell
mediat
inhibit
bystand
cell
rotavir
factor
respons
identifi
contrast
rv
inhibit
ifndirect
activ
rvinfect
cell
well
character
recent
find
demonstr
singlecel
level
rv
infect
result
effici
deplet
type
ii
iii
ifnr
within
rv
antigen
infect
cell
rvmediat
ifnr
degrad
unlik
direct
secret
ifn
ie
liganddepend
pathway
despit
prolong
infect
cell
restrict
exclus
subset
cell
express
deplet
ifnr
rvinfect
cell
occur
hour
postinfect
hpi
onward
pathway
protein
degrad
observ
rv
vp
antigen
uninfect
bystand
cell
nevertheless
highli
refractori
ifndirect
activ
fig
relev
rvmediat
ifnr
degrad
shown
vivo
signific
decreas
intestin
type
ii
ifnr
protein
express
small
intestin
follow
murin
rv
infect
degrad
differ
type
ifnr
rv
repres
ingeni
strategi
ensur
autocrin
ifn
antivir
amplif
inhibit
thu
allow
viral
replic
cell
cell
spread
proceed
effici
interestingli
find
indic
likelihood
rv
target
common
hostsign
pathway
respons
express
three
ifnr
continu
unravel
mechan
rv
also
inhibit
respons
differ
ifn
bystand
cell
import
sever
reason
first
sinc
level
rv
replic
substanti
determin
host
pathogen
inform
enabl
ration
attenu
homolog
heterolog
rv
strain
use
candid
thirdgener
live
vaccin
second
sever
diseas
includ
sepsi
system
lupu
erythematosu
excess
ifn
respons
undesir
implic
caus
andor
exacerb
trigger
diseas
situat
discov
novel
therapeut
modal
dampen
ifn
signal
potenti
valuabl
rv
strategi
also
identifi
direct
disrupt
signal
infect
abil
rv
perturb
signal
first
report
holloway
colleagu
observ
earli
hpi
sever
rv
strain
inhibit
nuclear
transloc
phosphoryl
respons
exogen
ifn
stimul
fig
although
viral
factor
respons
inhibitori
effect
downstream
activ
yet
identifi
possibl
redund
rv
inhibit
pathway
exist
perhap
indic
vital
role
inhibit
ifn
signal
enabl
rv
replic
abil
rv
protein
target
irf
proteasom
degrad
extend
two
addit
factor
critic
optim
amplif
ifndepend
antivir
respons
wherea
earli
induct
differ
ifn
antivir
transcript
mediat
primarili
ifnmedi
signal
result
increas
express
subsequ
orchestr
amplif
ifn
isg
ifnmedi
effect
transcript
sever
gene
includ
requir
assembl
transcript
complex
includ
role
degrad
ifndepend
respons
rv
infect
yet
well
studi
nevertheless
degrad
like
addit
weapon
rv
arsen
use
halt
effici
ifn
amplif
respons
fig
addit
ifn
induct
amplif
pathway
rv
equip
abil
block
downstream
effector
antivir
protein
one
exampl
ribonucleas
l
rnasel
key
enzym
ifninduc
oligoadenyl
synthetas
oa
rnasel
pathway
respons
potent
rna
degrad
includ
host
viral
rna
molecul
rv
rna
cap
enzym
encod
ctermin
phosphodiesteras
pde
domain
recent
shown
induc
degrad
oligoadenyl
second
messeng
respons
rnasel
activ
dimer
rv
pde
domain
function
replac
compar
domain
murin
coronaviru
protein
inhibit
rnasel
activ
recent
studi
suggest
anoth
yettob
identifi
mechan
also
exist
contribut
rv
inhibit
rnasel
howev
actual
physiolog
role
rnasel
modul
rv
replic
antagon
rnasel
vivo
remain
demonstr
current
two
timehonor
demonstr
success
approach
develop
safe
effect
human
viral
vaccin
first
case
wide
varieti
current
viral
vaccin
reli
parenter
administr
replicationincompet
inactiv
whole
viru
parenter
administr
viral
protein
compon
administr
molecularli
produc
viruslik
particl
vlp
entiti
select
immun
individu
protein
inactiv
whole
viru
vlp
induc
protect
immun
host
time
safe
well
toler
numer
highli
success
exampl
categori
viral
vaccin
eg
inactiv
polio
vaccin
variou
prepar
inactiv
influenza
hemagglutininbas
vaccin
human
papilloma
vlp
vaccin
hepat
b
viru
vaccin
recent
licens
herp
zoster
ge
proteinbas
vaccin
case
vaccin
administ
parenter
sever
administ
adjuv
one
kind
anoth
enhanc
immun
respons
case
appear
function
primarili
stimul
system
immun
primari
effector
function
gener
mediat
system
antibodi
note
none
type
vaccin
direct
predominantli
enter
pathogen
although
investig
potenti
parenter
administ
noroviru
vlp
vaccin
current
way
plan
studi
util
heatinactiv
rv
virionbas
vaccin
human
greatest
advantag
inactivatedrecombin
proteinbas
vaccin
gener
safeti
fact
produc
even
actual
pathogen
readili
propag
gener
disadvantag
vaccin
almost
alway
less
effect
stimul
tcellbas
immun
respons
effici
stimul
mucos
immun
respons
highli
effect
mucos
immun
adjuv
yet
readili
avail
case
immun
respons
inactiv
vaccin
prepar
tend
diminish
time
rapidli
respons
sever
live
viral
vaccin
potenti
disadvantag
inactiv
vaccin
becom
appar
antigen
antigen
requir
induc
protect
immun
difficult
synthes
artifici
immun
potent
direct
multipl
antigen
correctli
fold
actual
recombin
multiprotein
viral
particl
note
rv
least
two
separ
protein
target
protect
antibodi
cleav
enter
trypsin
two
separ
protein
compon
individu
target
protect
antibodi
respons
correctli
fold
proper
antigen
trimer
form
within
context
rv
virion
similar
issu
like
true
hand
rv
protein
rel
simpli
accur
synthes
sever
prokaryot
eukaryot
system
featur
current
examin
potenti
inactiv
vaccin
administ
parenter
chapter
develop
oral
rotaviru
noroviru
vaccin
second
highli
success
approach
human
viral
vaccin
develop
product
live
attenu
viral
vaccin
actual
infect
suscept
peopl
attenu
degre
level
reactogen
pathogen
accept
reliabl
gener
protect
immun
inactiv
vaccin
number
highli
effect
replicationcompet
viral
vaccin
current
avail
eg
oral
sabin
polio
vaccin
measl
vaccin
rubella
vaccin
yellow
fever
vaccin
smallpox
vaccin
live
attenu
influenza
vaccin
cours
sever
licens
rv
vaccin
rotateq
rotarix
rotavac
live
attenu
viral
vaccin
administ
parenter
inject
howev
oral
polio
rotaviru
live
attenu
influenza
vaccin
administ
mucos
surfac
gi
tract
respiratori
tract
respect
gener
think
live
attenu
viral
vaccin
close
mimic
type
level
immun
induc
natur
infect
parenter
administ
inactiv
vaccin
natur
infect
effect
prevent
sever
secondari
infect
reproduc
without
undu
reactogen
desir
featur
present
natur
immun
oper
primarili
mucos
surfac
case
rv
natur
rv
infect
effici
protect
sever
reinfect
reason
varieti
experiment
licens
live
attenu
rv
vaccin
develop
propos
key
issu
overcom
develop
live
viral
vaccin
discov
method
reliabl
attenu
viral
pathogen
retain
abil
viral
infect
induc
protect
immun
tradit
modif
accomplish
multipl
passag
virul
viral
strain
cell
cultur
hope
multipl
passag
lead
acquisit
suffici
mutat
viral
genom
acquir
enhanc
cell
cultur
replic
cell
cultur
adapt
attenu
viral
pathogen
target
host
strategi
vi
mucos
vaccin
viral
diseas
time
honor
use
develop
multipl
vaccin
eg
live
polio
measl
mump
rubella
yellow
fever
rv
vaccin
approach
frequent
success
way
determin
mani
passag
need
elimin
residu
virul
retain
immunogen
often
tediou
alway
inexact
approach
addit
concern
revers
virul
alway
present
said
approach
use
success
develop
highli
effect
human
rv
vaccin
rotarix
consist
singl
human
rv
strain
repeat
pass
sever
cell
cultur
system
passag
histori
becam
attenu
peopl
genom
sequenc
virul
wildtyp
parent
rotarix
strain
eventu
vaccin
strain
known
exact
genom
mutat
respons
attenu
unclear
establish
howev
given
substanti
decadelong
safeti
record
human
rv
vaccin
strain
suffici
attenu
mutat
ensur
high
degre
genet
stabil
human
note
rotarix
vaccin
repres
singl
g
p
serotyp
yet
reliabl
induc
protect
immun
virtual
frequent
circul
human
rv
strain
find
strongli
support
conclus
serotypespecif
immun
major
determin
immun
sever
rv
diseas
human
strategi
proven
highli
success
reproduc
attenu
rv
use
live
attenu
rv
vaccin
take
advantag
hrr
see
heterolog
nonhuman
origin
rv
vaccin
candid
human
sever
current
licens
rv
vaccin
eg
vaccin
rotateq
rotasil
vaccin
rotavac
consist
either
natur
experiment
select
reassort
anim
rv
case
bovin
rv
human
rv
vaccin
pentaval
construct
deriv
experiment
basi
bovin
rv
genom
contain
individu
gene
deriv
variou
human
serotyp
rotateq
broadli
licens
around
world
rotasil
current
licens
india
rotavac
interestingli
natur
occur
reassort
rv
deriv
human
rv
bovin
rv
contain
bovin
ten
rv
gene
segment
deriv
human
rv
strain
viru
origin
isol
neonat
nurseri
asymptomat
rv
infect
endem
final
relev
review
entir
lamb
origin
rv
strain
current
licens
rv
prevent
china
vaccin
also
highli
attenu
presum
hrr
lamb
origin
rv
human
vaccin
seem
safe
data
efficaci
limit
key
point
anim
viru
origin
base
rv
vaccin
highli
attenu
human
attenu
discuss
like
base
host
rang
replic
restrict
human
hrr
primarili
due
inabl
heterolog
rv
effici
suppress
human
intestin
innat
immun
respons
primarili
human
ifn
respons
owe
presenc
heterolog
vaccin
candid
activ
human
ifn
respons
heterolog
rv
vaccin
suppress
replic
suffici
restrict
pathogen
reactogen
much
gener
effect
rv
immun
suppress
howev
case
indian
rotavac
vaccin
attenu
might
base
heterolog
bovin
origin
might
expect
reduc
rv
bind
human
iec
big
question
futur
whether
advent
tractabl
revers
genet
system
improv
understand
genet
determin
hrr
abl
better
finetun
replic
compet
immunogen
potenti
rv
vaccin
candid
enhanc
efficaci
